Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$542.50 -6.54 (-1.19%)
At close: Nov 5, 2026 · 4:00 PM EST

Vertex Pharmaceuticals (VRTX) Work In Process (2011 - 2012)

Updated

Vertex Pharmaceuticals (VRTX) recorded Work In Process of $58.45 million in Q3 2012, up 64.4% from $35.54 million a year earlier but down 1.3% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Work In Process (2011 - 2012) Analysis & Trends

At the end of FY2011, Vertex Pharmaceuticals reported Work In Process of $47.01 million.

  • Quarterly Work In Process has ranged from $10 million in Q1 2011 to $74.74 million in Q1 2012 over the past five years.
  • On a year-over-year basis, Work In Process has increased for three consecutive quarters.
  • Per Business Quant, the preceding three quarters came in at $59.22 million (Q2 2012), $74.74 million (Q1 2012) and $47.01 million (Q4 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn
5 Novartis Ag 313.89 Bn 287.12 Bn -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn
10 Vertex Pharmaceuticals 137.20 Bn 109.19 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 58.45 Mn
Jun 30, 2012 59.22 Mn
Mar 31, 2012 74.74 Mn
Dec 31, 2011 47.01 Mn
Sep 30, 2011 35.54 Mn
Jun 30, 2011 29.27 Mn
Mar 31, 2011 10.00 Mn
API Access

Vertex Pharmaceuticals Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=VRTX&period=max&api_key=YOUR_API_KEY